Vaxil BioTherapeutics' Reverse Merger Round

Vaxil BioTherapeutics raised a round of funding on March 10, 2016. Investors include Emerge Resources Corp..

Vaxil BioTherapeutics is a biotechnology firm focused on cancer treatments. Years of research have culminated in a significant cancer immunotherapy vaccine platform including a lead cancer vaccine can…

Articles about Vaxil BioTherapeutics' Reverse Merger Round: